Shire Pharmaceuticals Release: Extended-Release Carbamazepine Capsules Effective In Treating Acute Manic And Mixed Episodes Of Bipolar I Disorder

Shire Pharmaceuticals Inc. has announced that University of North Carolina at Chapel Hill researchers studied the efficacy of carbamazepine extended-release capsules (CBZ-ERC, EquetroTM) in patients with manic or mixed episodes of Bipolar I Disorder over six months. Data from this open label study was presented by UNC researchers last week at the 18th annual U.S. Psychiatric and Mental Health Congress in Las Vegas.

Back to news